Headache News

SAN DIEGO — Treating migraine with a novel formulation of dihydroergotamine powder was linked to favorable outcomes including significant headache pain reduction at 48 hours post dose that was extended to 12 months.

SAN DIEGO —– New daily persistent headache presents itself relatively early in life, is commonly triggered by stress and leads to stigma and disability, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — In a small cohort of young people, use of gepants to treat headache led to some therapeutic benefit and led to few adverse events, according to a poster from the American Headache Society Annual Scientific Meeting.

SAN DIEGO — A wearable remote electrical neuromodulation device provided consistent efficacy and clinically meaningful benefit to those with migraine, according to a poster presentation at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — For younger people with migraine, lidocaine injections were linked to better outcomes compared with saline injections, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Obtaining serum vitamin levels in children with migraine should be part of symptom management, particularly for older adolescents, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Distinctions between burdens faced by those who experience different levels of chronic and episodic migraine should be drawn according to external health care-related factors rather than by symptoms alone, according to a poster.

SAN DIEGO — Patients with migraine who received daytime psilocybin experienced reduced REM sleep, with effects lasting beyond the day of administration, according to a poster at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — A novel, oral therapeutic for treatment of migraine was safe and well-tolerated in single ascending doses in a cohort of healthy adults, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — The stigma that accompanies migraine is universal and often affects more than one personal or professional relationship, according to a speaker at the American Headache Society Annual Scientific Meeting.